🇺🇸 ROIV — Roivant Sciences Ltd.

Salud Compra fuerte
← Volver

Precio actual

36,04 USD

Máx. histórico

41,81

55 días

Caída desde máximo

-13,80%

Rango 52 semanas

19,32 – 42,50

Variación hoy

+0,42%

Cierre anterior

35,89

Rango de hoy

35,56 – 36,78

Volumen hoy

6.686.435

Peor caída histórica

-79,22%

20/12/2021 → 12/05/2022

Recuperado en 1217 días

Volatilidad anualizada ⓘ

55,48%

Información
Nombre completo
Roivant Sciences Ltd.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
721
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
50,00 USD (puede no estar actualizado)
Primera cotización
08/12/2020
Precio actualizado
hace 13 horas
Sobre la empresa

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease; neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising a lipid nanoparticle (LNP) platform and a ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
29/06/2023 10,16 10,51 9,78 9,90 -1,69% 7,19% 5.779.300
28/06/2023 9,18 10,11 8,83 10,07 +11,27% 13,94% 9.533.400
27/06/2023 9,15 9,19 8,41 9,05 -1,42% 8,52% 10.414.500
26/06/2023 9,71 9,72 9,06 9,18 -6,33% 6,80% 6.946.300
23/06/2023 10,00 10,27 9,73 9,80 -1,71% 5,40% 23.965.600
22/06/2023 10,05 10,83 9,78 9,97 +4,62% 10,45% 24.503.400
21/06/2023 9,75 9,76 9,30 9,53 -2,66% 4,71% 3.630.800
20/06/2023 9,52 9,83 9,42 9,79 +1,45% 4,31% 3.088.200
16/06/2023 10,00 10,04 9,54 9,65 -2,72% 5,00% 5.959.500
15/06/2023 9,63 9,93 9,53 9,92 +2,16% 4,15% 1.734.400
14/06/2023 9,80 9,83 9,48 9,71 -0,72% 3,57% 1.820.700
13/06/2023 9,45 9,81 9,40 9,78 +3,82% 4,29% 2.279.500
12/06/2023 10,05 10,08 9,30 9,42 -6,08% 7,76% 3.531.800
09/06/2023 9,63 10,12 9,50 10,03 +4,70% 6,44% 6.169.400
08/06/2023 9,65 9,73 8,76 9,58 -1,74% 10,05% 4.971.500
07/06/2023 9,80 9,85 9,64 9,75 +0,00% 2,14% 3.919.200
06/06/2023 9,49 9,84 9,35 9,75 +3,50% 5,16% 3.718.900
05/06/2023 9,44 9,49 9,23 9,42 -0,21% 2,70% 1.563.500
02/06/2023 9,42 9,46 9,31 9,44 +0,96% 1,65% 1.659.900
01/06/2023 9,03 9,39 8,89 9,35 +2,86% 5,54% 2.789.800
31/05/2023 9,08 9,36 8,95 9,09 +0,22% 4,52% 4.534.100
30/05/2023 9,25 9,48 9,01 9,07 -2,58% 5,08% 1.471.100
26/05/2023 9,22 9,35 9,16 9,31 +0,87% 2,06% 1.922.800
25/05/2023 9,26 9,33 8,96 9,23 +0,11% 3,97% 1.965.800
24/05/2023 9,32 9,33 9,05 9,22 -1,81% 3,00% 1.897.900
23/05/2023 9,66 9,85 9,33 9,39 -2,80% 5,38% 2.864.100
22/05/2023 9,25 9,70 9,23 9,66 +3,65% 5,08% 2.757.600
19/05/2023 9,15 9,33 9,11 9,32 +2,53% 2,35% 1.856.600
18/05/2023 9,20 9,38 8,95 9,09 +0,55% 4,62% 2.846.900
17/05/2023 8,81 9,09 8,73 9,04 +3,43% 4,09% 2.656.000